Sleep Apnea Devices Market Size, Share & Trends by products (Therapeutic (PAP ), Facial Interfaces, Oral Appliances, Accessories), Diagnostic Devices, Age Group, Gender type, End User & Region - Global Forecasts to 2029
세계의 수면 무호흡증용 기기 시장 규모는 2024년에 추정 65억 달러로 평가되었고, 2029년까지 93억 달러에 이를 것으로 예측되며, 예측 기간에 CAGR로 7.3%의 성장이 예상됩니다.
수면 무호흡증용 기기는 수면 연구소, 클리닉, 병원 및 가정 사용자에 의해 널리 사용됩니다. 환자는 비침습성 치료법을 선호하기 때문에 CPAP 기계와 BPAP 기계와 같은 장비의 사용이 증가하고 있습니다. 아시아태평양과 같은 신흥 시장은 시장에 유리한 성장 기회를 제공합니다.
| 조사 범위 |
| 조사 대상년도 |
2022-2029년 |
| 기준년 |
2023년 |
| 예측 기간 |
2024-2029년 |
| 단위 |
10억 달러 |
| 부문 |
제품별, 최종 사용자별, 연령대별, 성별 |
| 대상 지역 |
북미, 유럽, 아시아태평양, 라틴아메리카, 중동 및 아프리카, GCC 국가 |
'제품별로는 치료기기 부문이 예측 기간에 시장에서 가장 높은 성장률을 차지합니다.'
이 부문의 주요 성장 촉진요인은 치료 기기 수요로 이어지는 재택 수면 검사에 의해 지원되는 진단 비율의 향상 등입니다.
'최종 사용자별로는 가정 관리 환경 및개인 부문이 예측 기간 동안 시장에서 가장 높은 성장률을 차지합니다.'
가정용 의료 솔루션에 대한 선호도가 높아짐에 따라 가정용 수면 무호흡증용 기기의 채택이 촉진됩니다. 가정에서 수면 무호흡증 검사에 대한 좋은 접근성은 수면 무호흡증 진단과 후속 치료를 향상시켜 시장 성장에 영향을 미치고 있습니다.
본 보고서에서는 세계의 수면 무호흡증용 기기 시장에 대해 조사 분석하여 주요 촉진요인 및 억제요인, 경쟁 구도, 미래 동향 등의 정보를 제공합니다.
목차
제1장 서론
제2장 조사 방법
제3장 주요 요약
제4장 중요 인사이트
- 수면 무호흡증용 기기 시장 개요
- 수면 무호흡증용 기기 시장 : 제품별(2024-2029년)
- 북미의 수면 무호흡증용 기기 시장 : 제품별, 국가별(2023년)
- 지리적 성장 기회(2024-2029년)
제5장 시장 개요
- 서문
- 시장 역학
- 가격 분석
- 수면 무호흡증용 기기의 평균 판매 가격 : 지역별
- 평균 판매 가격 범위 : 제품 유형별
- 밸류체인 분석
- 공급망 분석
- Porter's Five Forces 분석
- 주요 이해관계자 및 구매 기준
- 생태계 분석
- 규제 분석
- 규제 상황
- 규제기관, 정부기관 및 기타 조직 목록
- 특허 분석
- 고객의 비즈니스에 영향을 미치는 동향 및 혼란
- 주요 컨퍼런스 및 이벤트(2024-2025년)
- 기술 분석
- 무역 분석
- HS코드 901920의 수입 데이터
- HS코드 901920의 수출 데이터
- 투자 및 자금조달 시나리오
- 수면 무호흡증용 기기 시장에 대한 생성형 AI의 영향
제6장 수면 무호흡증의 역학적 평가
- 서문
- 역학적 평가
- 처방 패턴 평가
- 어드히어런스의 평가
제7장 수면 무호흡증의 대체 요법
- 서문
- EPAP
- 설하신경자극
- 구강 가압 요법
- 체위요법
제8장 수면 무호흡증용 기기 시장 : 제품별
- 서문
- 치료기기
- PAP 기기
- CPAP 기기
- APAP 기기
- BPAP 기기
- 페이셜 인터페이스
- 액세서리
- 구강내 장치
- 기타 치료 장비
- 진단 기기
- PSG 기기
- 가정용 수면 검사 기기
- 옥시미터
- 액티그래피 시스템
- 수면 스크리닝 장비
제9장 수면 무호흡증용 기기 시장 : 최종 사용자별
- 서문
- 수면 연구소, 진료소 및 병원
- 재택 케어 환경 및 개인
제10장 수면 무호흡증용 기기 시장 : 연령층별
제11장 수면 무호흡증용 기기 시장 : 성별
제12장 수면 무호흡증용 기기 시장 : 지역별
- 서문
- 북미
- 유럽
- 아시아태평양
- 라틴아메리카
- 중동 및 아프리카
- GCC 국가
- 기타 GCC 국가
제13장 경쟁 구도
- 서문
- 주요 기업의 전략 및 유력 기업
- 수익 분석
- 시장 점유율 분석
- 기업의 평가 매트릭스 : 주요 기업(2023년)
- 기업의 평가 매트릭스 : 스타트업 및 중소기업(2023년)
- 기업 평가 및 재무 지표
- 브랜드 및 제품 비교
- 경쟁 시나리오
제14장 기업 프로파일
- 주요 기업
- RESMED
- KONINKLIJKE PHILIPS NV
- FISHER & PAYKEL HEALTHCARE LIMITED
- INSPIRE MEDICAL SYSTEMS, INC.
- SOMNOMED
- OPENAIRWAY
- COMPUMEDICS LIMITED
- LOWENSTEIN MEDICAL TECHNOLOGY GMBH CO. KG
- DRIVE DEVILBISS HEALTHCARE
- BMC MEDICAL CO., LTD.
- BRAEBON MEDICAL CORPORATION
- DYNAFLEX
- PANTHERA DENTAL
- MYERSON LLC
- PROSOMNUS SLEEP TECHNOLOGIES
- 기타 기업
- NIDEK MEDICAL INDIA
- TOMED GMBH
- LIVANOVA PLC
- INVACARE CORPORATION
- MPOWRX HEALTH & WELLNESS PRODUCTS INC.
- NIHON KOHDEN CORPORATION
- SICAT GMBH & CO. KG
- VIVOS THERAPEUTICS, INC.
- AIRWAY MANAGEMENT
- APNEA SCIENCES
제15장 부록
AJY
The sleep apnea devices market is valued at an estimated USD 6.5 billion in 2024 and is projected to reach USD 9.3 billion by 2029 at a CAGR of 7.3% during the forecast period. Sleep apnea devices is widely used by sleep laboratories, clinics, hospitals and home users. Patients prefer non-invasive treatment methods, leading to increased use of devices like CPAP and BPAP machines. Emeriging markets such as Asia Pacific region offer lucrative growth opportunities for sleep apnea devices market.
| Scope of the Report |
|---|
| Years Considered for the Study | 2022-2029 |
| Base Year | 2023 |
| Forecast Period | 2024-2029 |
| Units Considered | Value (USD Billion) |
| Segments | By Product, end user, age group and gender |
| Regions covered | North America, Europe, Asia Pacific, Latin America, the Middle East & Africa, and GCC countries |
"Therapeutic devices segment accounted for the highest growth rate in the sleep apnea devices market, by product, during the forecast period."
The sleep apnea devices market is bifurcated into therapeutic devices and diagnostic devices. Sleep apnea therapeutic devices covers positive airway pressure (PAP) devices, facial interfaces (masks), accessories, oral appliances, and other therapeutic devices. Major factors driving the growth of this segment include improving diagnosis rate backed by home sleep tests leading to demand for therapeutic devices.
"Home care settings/individuals segment accounted for the highest growth rate in the sleep apnea devices market, by end users, during the forecast period."
The sleep apnea devices market is bifurcated into into sleep laboratories, clinics, and hospitals and home care settings/individuals. The growing preference for home healthcare solutions is driving the adoption of home-use sleep apnea devices. Better accessibility of home sleep apnea tests is key reason for greater diagnosis and subsequent treatment of sleep apnea impacting market growth.
"Asia Pacific: The fastest-growing region sleep apnea devices market."
The worldwide market for human identification is categorized into North America, Europe, Asia Pacific, Latin America, the Middle East & Africa, and GCC countries. Notably, the Asia Pacific region market is expected to register the highest growth rate during the forecast period, mainly due to the frequent product launches and regulatory approvals of new devices leading to market offerings in the region.
The break-up of the profile of primary participants in the sleep apnea devices market:
- By Company Type: Tier 1 - 55%, Tier 2 - 40%, and Tier 3 - 5%
- By Designation: C-level - 37%, D-level - 48%, and Others - 15%
- By Region: North America - 56%, Europe - 20%, Asia Pacific - 17%, Rest of the World - 7%
The key players in this market are ResMed (US), Koninklijke Philips N.V. (Netherlands), Fisher & Paykel Healthcare Limited (New Zealand), Inspire Medical Systems, Inc. (US), SomnoMed (Australia), Openairway (Canada), Compumedics Limited (Australia), Lowenstein Medical Technology GmbH + Co. K.G. (Germany), Drive DeVilbiss Healthcare (US), BMC Medical Co., Ltd. (China), BRAEBON Medical Corporation (Canada), DynaFlex (US), Panthera Dental (Canada), Myerson LLC (US), ProSomnus Sleep Technologies (US), Nidek Medical India (India), Tomed GmbH (Germany), LivaNova PLC (UK), Invacare Corporation (US), MPowrx Health & Wellness Products Inc. (Canada), Nihon Kohden Corporation (Japan), SICAT GmbH & Co. Kg (Germany), Vivos Therapeutics, Inc. (US), Airway Management (US), and Apnea Sciences (US).
Research Coverage:
This research report categorizes the sleep apnea devices market by product (Therapeutic devices (PAP devices, facial interfaces, accessories, oral appliances, other therapeutic devices), Diagnostic devices (PSG Devices, home sleep testing devices, oximeters, actigraphy systems, sleep screening devices)), by end user (Sleep laboratories, clinics, and hospitals, and home care settings/ individuals), by age group (below 40 years, 40-60 years, and above 60 years), by gender (male patients, female patients), and by region (North America, Europe, Asia Pacific, Latin America, the Middle East & Africa and GCC countries). The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, opportunities, and challenges influencing the growth of the sleep apnea devices market. A detailed analysis of the key industry players has been done to provide insights into their business overview, solutions, key strategies, acquisitions, and agreements. New product & service launches and recent developments associated with the sleep apnea devices market. Competitive analysis of upcoming startups in the sleep apnea devices market ecosystem is covered in this report.
Reasons to buy this report:
The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall sleep apnea devices market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, opportunities, and challenges.
The report provides insights on the following pointers:
- Analysis of key drivers (large pool of undiagnosed sleep apnea patients, favorable reimbursement and financial aid for sleep apnea devices and therapies, growing awareness about effects of untreated sleep apnea among patients, increasing usage of oral appliances among patients with mild to low-moderate sleep apnea, increased investments and funding to develop advanced sleep apnea products), restraints (high cost of CPAP machines and minimal insurance access in emerging economies, complex referral pathways, long waiting periods, amd delayed diagnosis, and use of alternative therapies and medications for sleep apnea), opportunities (rising demand for sleep apnea tests as cost saving measures, imcreasing focus on telemedicine, mHealth, and artificial intelligence, growing focus of key sleep apnea device manufacturers toward emerging markets) and challenges (Poor patient compliance with CPAP therapy) influencing the growth of the sleep apnea devices market.
- Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product launches in the sleep apnea devices market.
- Market Development: Comprehensive information about lucrative markets - the report analyses the sleep apnea devices market across varied regions.
- Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the sleep apnea devices market
- Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings of leading players like ResMed (US), Koninklijke Philips N.V. (Netherlands), and Fisher & Paykel Healthcare Limited (New Zealand).
TABLE OF CONTENTS
1 INTRODUCTION
- 1.1 STUDY OBJECTIVES
- 1.2 MARKET DEFINITION
- 1.2.1 INCLUSIONS & EXCLUSIONS
- 1.3 STUDY SCOPE
- 1.3.1 SEGMENTS COVERED
- 1.3.2 REGIONS COVERED
- 1.3.3 YEARS CONSIDERED
- 1.3.4 CURRENCY CONSIDERED
- 1.4 STAKEHOLDERS
- 1.5 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY
- 2.1 RESEARCH DATA
- 2.1.1 SECONDARY DATA
- 2.1.1.1 List of key secondary sources
- 2.1.1.2 Key data from secondary sources
- 2.1.1.3 Objectives of secondary research
- 2.1.2 PRIMARY DATA
- 2.1.2.1 List of key primaries
- 2.1.2.2 Objectives of primary research
- 2.1.2.3 Key industry insights
- 2.1.2.4 Key data from primary sources
- 2.1.2.5 Breakdown of primary interviews
- 2.2 MARKET SIZE ESTIMATION
- 2.2.1 BOTTOM-UP APPROACH
- 2.2.1.1 Company revenue estimation approach
- 2.2.1.2 Company presentations and primary interviews
- 2.2.1.3 Patient-based approach (sleep apnea oral appliances)
- 2.2.1.4 Patient-based approach (PAP devices)
- 2.2.1.5 Growth forecast
- 2.2.1.6 CAGR projections
- 2.2.2 TOP-DOWN APPROACH
- 2.3 DATA TRIANGULATION
- 2.4 MARKET SHARE ANALYSIS
- 2.5 STUDY ASSUMPTIONS
- 2.6 RESEARCH LIMITATIONS
- 2.7 RISK ASSESSMENT
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
- 4.1 SLEEP APNEA DEVICES MARKET OVERVIEW
- 4.2 SLEEP APNEA DEVICES MARKET, BY PRODUCT (2024-2029)
- 4.3 NORTH AMERICA: SLEEP APNEA DEVICES MARKET, BY PRODUCT AND COUNTRY (2023)
- 4.4 GEOGRAPHIC GROWTH OPPORTUNITIES (2024-2029)
5 MARKET OVERVIEW
- 5.1 INTRODUCTION
- 5.2 MARKET DYNAMICS
- 5.2.1 DRIVERS
- 5.2.1.1 Large pool of undiagnosed sleep apnea patients
- 5.2.1.2 Favorable reimbursement and financial aid for sleep apnea devices and therapies
- 5.2.1.3 Growing awareness about effects of untreated sleep apnea among patients
- 5.2.1.4 Increasing usage of oral appliances among patients with mild-to-moderate sleep apnea
- 5.2.1.5 Increased investments and funding to develop advanced sleep apnea products
- 5.2.2 RESTRAINTS
- 5.2.2.1 High cost of CPAP machines and minimal insurance access in emerging economies
- 5.2.2.2 Complex referral pathways, long waiting periods, and delayed diagnosis
- 5.2.2.3 Use of alternative therapies and medications for sleep apnea
- 5.2.3 OPPORTUNITIES
- 5.2.3.1 Rising demand for cost-effective home sleep apnea tests
- 5.2.3.2 Increasing focus on telemedicine, mHealth, and artificial intelligence
- 5.2.3.3 Growing focus of key sleep apnea device manufacturers toward emerging markets
- 5.2.4 CHALLENGES
- 5.2.4.1 Poor patient compliance with CPAP therapy
- 5.3 PRICING ANALYSIS
- 5.3.1 AVERAGE SELLING PRICE OF SLEEP APNEA PRODUCTS, BY REGION
- 5.3.2 AVERAGE SELLING PRICE RANGE, BY PRODUCT TYPE
- 5.4 VALUE CHAIN ANALYSIS
- 5.5 SUPPLY CHAIN ANALYSIS
- 5.6 PORTER'S FIVE FORCES ANALYSIS
- 5.6.1 THREAT OF NEW ENTRANTS
- 5.6.2 THREAT OF SUBSTITUTES
- 5.6.3 BARGAINING POWER OF SUPPLIERS
- 5.6.4 BARGAINING POWER OF BUYERS
- 5.6.5 INTENSITY OF COMPETITIVE RIVALRY
- 5.7 KEY STAKEHOLDERS & BUYING CRITERIA
- 5.7.1 KEY STAKEHOLDERS IN BUYING PROCESS
- 5.7.2 KEY BUYING CRITERIA
- 5.8 ECOSYSTEM ANALYSIS
- 5.9 REGULATORY ANALYSIS
- 5.9.1 REGULATORY LANDSCAPE
- 5.9.1.1 North America
- 5.9.1.1.1 US
- 5.9.1.1.1.1 Reimbursement scenario in US
- 5.9.1.1.2 Canada
- 5.9.1.2 Europe
- 5.9.1.3 Asia Pacific
- 5.9.1.3.1 Japan
- 5.9.1.3.2 China
- 5.9.1.3.3 India
- 5.9.1.3.4 Australia
- 5.9.2 LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
- 5.9.2.1 List of key regulatory bodies, government agencies, and other organizations
- 5.9.2.1.1 North America
- 5.9.2.1.2 Europe
- 5.9.2.1.3 Asia Pacific
- 5.9.2.1.4 Latin America
- 5.9.2.1.5 Middle East & Africa
- 5.9.2.2 List of other regulatory bodies, government agencies, and other organizations
- 5.1 PATENT ANALYSIS
- 5.11 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
- 5.11.1 REVENUE SHIFT AND POCKETS FOR SLEEP APNEA ORAL APPLIANCE MANUFACTURERS
- 5.12 KEY CONFERENCES & EVENTS, 2024-2025
- 5.13 TECHNOLOGY ANALYSIS
- 5.13.1 KEY TECHNOLOGIES
- 5.13.2 ADJACENT TECHNOLOGIES
- 5.14 TRADE ANALYSIS
- 5.14.1 IMPORT DATA FOR HS CODE 901920
- 5.14.2 EXPORT DATA FOR HS CODE 901920
- 5.15 INVESTMENT & FUNDING SCENARIO
- 5.16 IMPACT OF GENERATIVE AI ON SLEEP APNEA DEVICES MARKET
6 EPIDEMIOLOGICAL ASSESSMENT OF SLEEP APNEA
- 6.1 INTRODUCTION
- 6.2 EPIDEMIOLOGICAL ASSESSMENT
- 6.3 PRESCRIPTION PATTERN ASSESSMENT
- 6.4 ADHERENCE ASSESSMENT
7 ALTERNATE THERAPIES FOR SLEEP APNEA
- 7.1 INTRODUCTION
- 7.2 EXPIRATORY PAP
- 7.3 HYPOGLOSSAL NERVE STIMULATION
- 7.4 ORAL PRESSURE THERAPY
- 7.5 POSITIONAL THERAPY
8 SLEEP APNEA DEVICES MARKET, BY PRODUCT
- 8.1 INTRODUCTION
- 8.2 THERAPEUTIC DEVICES
- 8.2.1 PAP DEVICES
- 8.2.2 CPAP DEVICES
- 8.2.2.1 Technological advancements and better reimbursement facilities to boost segment growth
- 8.2.3 APAP DEVICES
- 8.2.3.1 Increasing patient non-compliance with CPAP devices to augment segment growth
- 8.2.4 BPAP DEVICES
- 8.2.4.1 Increased product recalls and more complex operations to lower adoption
- 8.2.5 FACIAL INTERFACES
- 8.2.5.1 Masks
- 8.2.5.1.1 Full-face masks
- 8.2.5.1.1.1 Full-face masks to be most effective for mouth breathers or patients struggling with breathing through nose
- 8.2.5.1.2 Nasal pillow masks
- 8.2.5.1.2.1 Greater patient compliance and high preference for masks without headgear or straps to support segment
- 8.2.5.1.3 Nasal masks
- 8.2.5.1.3.1 Ease of use and less claustrophobic nature to aid adoption
- 8.2.5.2 Cushions
- 8.2.5.2.1 Favorable insurance coverage to propel segment growth
- 8.2.6 ACCESSORIES
- 8.2.6.1 Humidifier accessories
- 8.2.6.1.1 Humidifiers to open airways, decrease congestion, and encourage clearer breathing
- 8.2.6.2 Power accessories
- 8.2.6.2.1 Power accessories to manage uninterrupted sleep apnea therapy in absence of power supply
- 8.2.6.3 Transportation accessories
- 8.2.6.3.1 Need to carry sleep apnea devices while traveling to spur segment growth
- 8.2.6.4 Communication accessories
- 8.2.6.4.1 Increasing need for easy teleconsultations for remote patients to fuel segment growth
- 8.2.6.5 Chain restraints
- 8.2.6.5.1 Growing need for obstructive sleep apnea management with therapeutic devices to drive segment
- 8.2.6.6 Other accessories
- 8.2.7 ORAL APPLIANCES
- 8.2.7.1 Mandibular advancement devices
- 8.2.7.1.1 Low cost and better research on device advantages to propel market growth
- 8.2.7.2 Tongue-retaining devices
- 8.2.7.2.1 Need for more affordable and comfortable treatment options to support segment growth
- 8.2.7.3 Daytime-Nighttime appliances
- 8.2.7.3.1 Increased focus on comfortable, non-surgical, and low-risk treatments to drive segment
- 8.2.8 OTHER THERAPEUTIC DEVICES
- 8.3 DIAGNOSTIC DEVICES
- 8.3.1 PSG DEVICES
- 8.3.1.1 Ambulatory PSG devices
- 8.3.1.1.1 High need for cost-effective and technologically advanced devices to propel segment growth
- 8.3.1.2 Clinical PSG devices
- 8.3.1.2.1 Labor-intensive and expensive procedures to limit segment
- 8.3.2 HOME SLEEP TESTING DEVICES
- 8.3.2.1 Increased need for cost-effective and comfortable home sleep testing devices to augment segment growth
- 8.3.3 OXIMETERS
- 8.3.3.1 Fingertip oximeters
- 8.3.3.1.1 Lack of precise reading due to injury or slow blood flow to limit segment
- 8.3.3.2 Handheld oximeters
- 8.3.3.2.1 Easy customizations and ease of distant reading to spur segment growth
- 8.3.3.3 Wrist-worn oximeters
- 8.3.3.3.1 Small size and easy portability for overnight monitoring to propel segment growth
- 8.3.3.4 Tabletop oximeters
- 8.3.3.4.1 Higher cost and fewer applications for personal use to decrease market share
- 8.3.4 ACTIGRAPHY SYSTEMS
- 8.3.4.1 Increased research on sleep and wake patterns to drive market
- 8.3.5 SLEEP SCREENING DEVICES
- 8.3.5.1 Increasing preference for home-based sleep apnea testing to propel market growth
9 SLEEP APNEA DEVICES MARKET, BY END USER
- 9.1 INTRODUCTION
- 9.2 SLEEP LABORATORIES, CLINICS, AND HOSPITALS
- 9.2.1 INCREASING NEED FOR ADVANCED DIAGNOSTIC DEVICES AND HIGHLY PRECISE DIAGNOSIS TO SUPPORT MARKET GROWTH
- 9.3 HOME CARE SETTINGS/INDIVIDUALS
- 9.3.1 INCREASING PATIENT PREFERENCE FOR HOME-BASED SLEEP TESTS TO FUEL MARKET GROWTH
10 SLEEP APNEA DEVICES MARKET, BY AGE GROUP
- 10.1 INTRODUCTION
- 10.2 BELOW 40 YEARS
- 10.2.1 LOWER PREVALENCE OF SLEEP APNEA IN YOUNGER AGE GROUPS TO LIMIT MARKET GROWTH
- 10.3 40-60 YEARS
- 10.3.1 UNDERDIAGNOSIS AND UNHEALTHY LIFESTYLE TO AID MARKET GROWTH
- 10.4 ABOVE 60 YEARS
- 10.4.1 HIGH OCCURRENCE OF CHRONIC MEDICAL CONDITIONS AND SLEEP-RELATED DISORDERS TO DRIVE MARKET
11 SLEEP APNEA DEVICES MARKET, BY GENDER
- 11.1 INTRODUCTION
- 11.2 MALE PATIENTS
- 11.2.1 HIGHER PREVALENCE OF SLEEP-RELATED BREATHING DISORDERS TO BOOST MARKET GROWTH
- 11.3 FEMALE PATIENTS
- 11.3.1 UNDERDIAGNOSIS OF OBSTRUCTIVE SLEEP APNEA TO LIMIT MARKET
12 SLEEP APNEA DEVICES MARKET, BY REGION
- 12.1 INTRODUCTION
- 12.2 NORTH AMERICA
- 12.2.1 US
- 12.2.1.1 US to dominate North American sleep apnea devices market during forecast period
- 12.2.2 CANADA
- 12.2.2.1 Increasing number of research grants and health programs to propel market growth
- 12.3 EUROPE
- 12.3.1 GERMANY
- 12.3.1.1 High prevalence of obstructive sleep apnea and increased geriatric population to fuel market
- 12.3.2 UK
- 12.3.2.1 Rising awareness among patients about sleep apnea to support market growth
- 12.3.3 FRANCE
- 12.3.3.1 Rising geriatric population and obesity rates to fuel market growth
- 12.3.4 ITALY
- 12.3.4.1 Favorable initiatives by dental associations and increased awareness about obstructive sleep apnea to drive market
- 12.3.5 SPAIN
- 12.3.5.1 Social awareness initiatives by regional organizations to aid market growth
- 12.3.6 REST OF EUROPE
- 12.4 ASIA PACIFIC
- 12.4.1 CHINA
- 12.4.1.1 Growing obesity and diabetes in adults to propel market growth
- 12.4.2 JAPAN
- 12.4.2.1 Favorable reimbursement scenario and high demand for cloud-connected sleep apnea therapeutic devices to aid market growth
- 12.4.3 AUSTRALIA
- 12.4.3.1 Increased number of sleep clinics to augment market growth
- 12.4.4 REST OF ASIA PACIFIC
- 12.5 LATIN AMERICA
- 12.5.1 BRAZIL
- 12.5.1.1 Favorable reimbursement policies and increased awareness about sleeping disorders to drive market
- 12.5.2 MEXICO
- 12.5.2.1 Poor healthcare infrastructure and lack of public health initiatives to limit market growth
- 12.5.3 REST OF LATIN AMERICA
- 12.6 MIDDLE EAST & AFRICA
- 12.6.1 PRESENCE OF KEY INTERNATIONAL PLAYERS AND HIGH INCIDENCE OF CHRONIC DISEASES TO DRIVE MARKET
- 12.7 GCC COUNTRIES
- 12.7.1 SAUDI ARABIA
- 12.7.1.1 High obesity rates among women to propel market growth
- 12.7.2 UAE
- 12.7.2.1 Improved access to diagnostics to drive adoption of sleep apnea devices
- 12.8 REST OF GCC COUNTRIES
13 COMPETITIVE LANDSCAPE
- 13.1 INTRODUCTION
- 13.2 KEY PLAYER STRATEGY/RIGHT TO WIN
- 13.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN SLEEP APNEA DEVICES MARKET
- 13.3 REVENUE ANALYSIS
- 13.4 MARKET SHARE ANALYSIS
- 13.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
- 13.5.1 STARS
- 13.5.2 EMERGING LEADERS
- 13.5.3 PERVASIVE PLAYERS
- 13.5.4 PARTICIPANTS
- 13.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
- 13.5.5.1 Company footprint
- 13.5.5.2 Product footprint
- 13.5.5.3 Region footprint
- 13.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
- 13.6.1 PROGRESSIVE COMPANIES
- 13.6.2 RESPONSIVE COMPANIES
- 13.6.3 DYNAMIC COMPANIES
- 13.6.4 STARTING BLOCKS
- 13.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
- 13.7 COMPANY VALUATION & FINANCIAL METRICS
- 13.8 BRAND/PRODUCT COMPARISON
- 13.9 COMPETITIVE SCENARIO
- 13.9.1 PRODUCT LAUNCHES & APPROVALS
- 13.9.2 DEALS
- 13.9.3 EXPANSIONS
- 13.9.4 OTHER DEVELOPMENTS
14 COMPANY PROFILES
- 14.1 KEY PLAYERS
- 14.1.1 RESMED
- 14.1.1.1 Business overview
- 14.1.1.2 Products offered
- 14.1.1.3 Recent developments
- 14.1.1.3.1 Product launches
- 14.1.1.3.2 Deals
- 14.1.1.3.3 Expansions
- 14.1.1.4 MnM view
- 14.1.1.4.1 Key strengths
- 14.1.1.4.2 Strategic choices
- 14.1.1.4.3 Weaknesses & competitive threats
- 14.1.2 KONINKLIJKE PHILIPS N.V.
- 14.1.2.1 Business overview
- 14.1.2.2 Products offered
- 14.1.2.3 MnM view
- 14.1.2.3.1 Key strengths
- 14.1.2.3.2 Strategic choices
- 14.1.2.3.3 Weaknesses & competitive threats
- 14.1.3 FISHER & PAYKEL HEALTHCARE LIMITED
- 14.1.3.1 Business overview
- 14.1.3.2 Products offered
- 14.1.3.3 Recent developments
- 14.1.3.3.1 Product launches
- 14.1.3.4 MnM view
- 14.1.3.4.1 Key strengths
- 14.1.3.4.2 Strategic choices
- 14.1.3.4.3 Weaknesses & competitive threats
- 14.1.4 INSPIRE MEDICAL SYSTEMS, INC.
- 14.1.4.1 Business overview
- 14.1.4.2 Products offered
- 14.1.5 SOMNOMED
- 14.1.5.1 Business overview
- 14.1.5.2 Products offered
- 14.1.6 OPENAIRWAY
- 14.1.6.1 Business overview
- 14.1.6.2 Products offered
- 14.1.7 COMPUMEDICS LIMITED
- 14.1.7.1 Business overview
- 14.1.7.2 Products offered
- 14.1.7.3 Recent developments
- 14.1.7.3.1 Product approvals
- 14.1.8 LOWENSTEIN MEDICAL TECHNOLOGY GMBH + CO. KG
- 14.1.8.1 Business overview
- 14.1.8.2 Products offered
- 14.1.9 DRIVE DEVILBISS HEALTHCARE
- 14.1.9.1 Business overview
- 14.1.9.2 Products offered
- 14.1.10 BMC MEDICAL CO., LTD.
- 14.1.10.1 Business overview
- 14.1.10.2 Products offered
- 14.1.11 BRAEBON MEDICAL CORPORATION
- 14.1.11.1 Business overview
- 14.1.11.2 Products offered
- 14.1.12 DYNAFLEX
- 14.1.12.1 Business overview
- 14.1.12.2 Products offered
- 14.1.12.3 Recent developments
- 14.1.13 PANTHERA DENTAL
- 14.1.13.1 Business overview
- 14.1.13.2 Products offered
- 14.1.13.3 Recent developments
- 14.1.13.3.1 Deals
- 14.1.13.3.2 Other developments
- 14.1.14 MYERSON LLC
- 14.1.14.1 Business overview
- 14.1.14.2 Products offered
- 14.1.15 PROSOMNUS SLEEP TECHNOLOGIES
- 14.1.15.1 Business overview
- 14.1.15.2 Products offered
- 14.1.15.3 Recent developments
- 14.2 OTHER PLAYERS
- 14.2.1 NIDEK MEDICAL INDIA
- 14.2.2 TOMED GMBH
- 14.2.3 LIVANOVA PLC
- 14.2.3.1 Recent developments
- 14.2.3.1.1 Product approvals
- 14.2.4 INVACARE CORPORATION
- 14.2.5 MPOWRX HEALTH & WELLNESS PRODUCTS INC.
- 14.2.6 NIHON KOHDEN CORPORATION
- 14.2.7 SICAT GMBH & CO. KG
- 14.2.8 VIVOS THERAPEUTICS, INC.
- 14.2.8.1 Recent developments
- 14.2.8.1.1 Product approvals
- 14.2.8.1.2 Deals
- 14.2.8.1.3 Expansions
- 14.2.9 AIRWAY MANAGEMENT
- 14.2.9.1 Recent developments
- 14.2.9.1.1 Product launches
- 14.2.10 APNEA SCIENCES
15 APPENDIX
- 15.1 DISCUSSION GUIDE
- 15.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
- 15.3 CUSTOMIZATION OPTIONS
- 15.4 RELATED REPORTS
- 15.5 AUTHOR DETAILS
